A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
KaliVir Immunotherapeutics
Psyence Australia Pty Ltd
Dana-Farber Cancer Institute
Tizona Therapeutics, Inc
Essen Biotech
University of Nebraska
Elephas
Elephas
Degron Therapeutics Co.
University Health Network, Toronto
University of Aarhus
Massive Bio, Inc.
Hadassah Medical Organization
Fudan University
Institut Claudius Regaud
Columbia University
Sheffield Teaching Hospitals NHS Foundation Trust
University Health Network, Toronto
Hospices Civils de Lyon
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
European Organisation for Research and Treatment of Cancer - EORTC
Second Affiliated Hospital of Guangzhou Medical University
N.N. Petrov National Medical Research Center of Oncology
Shanghai Yunying Medical Technology
Hospices Civils de Lyon